If you have been NEWLY DIAGNOSED START HERE
For our 5th video in the GRACE Spanish Lung Cancer Library, Antonio Calles, MD joined GRACE to discuss the most appropriate treatment for elderly patients with advanced NSCLC, and whether age alters the recommendations.
For our 4th video in the GRACE Spanish Lung Cancer Library, Antonio Calles, MD joined GRACE to discuss what the role of Avastin (bevacizumab) is in treating advanced NSCLC today.
In this sixteenth and final video from the Targeted Therapies Patient Forum, the eighth from the afternoon breakout survivorship sessions, we present "Recharging the Caregivers Batteries", with Jeanice Hansen, MSW, LCSW, OSW-C.
In this fifteenth video from the Targeted Therapies in Lung Cancer Patient Forum, we present the seventh from the afternoon breakout survivorship sessions, "Where There's Smoke, Is There Fire? Marijuana and Lung Cancer", presented by Dr. Dan Bowles.
During the Targeted Therapies in Lung Cancer Patient Forum, many of our fantastic and loved attendees shared with us what they are grateful for. For our sixth video in this month of gratitude, Ann Broo shared what she is thankful for with GRACE.
Christine M. Walko, Pharm.D., discusses how advancements in technology have improved the quality, cost and turnaround time for assessing genetic mutations in tumor tissue, and how this has helped to translate precision medicine into standard clinical practice.
Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Medical Director at Memorial Cancer Institute, Clinical Associate Prof. of Medicine at FL International University provides an update regarding current immunotherapy agents in development for lung cancer.
It’s #GivingTuesday and we're out to win up to $50,000 in the Newman’s Own Foundation $500k Holiday Challenge. Help GRACE so we can continue to help others!
Let me start by saying that I'm a fan of the immune checkpoint inhibitor Keytruda (pembrolizumab) and consider it the new standard of care as a single...
Let me start by saying that I'm a fan of the immune checkpoint inhibitor Keytruda (pembrolizumab) and consider it the new standard of care as a single...
This question is not for a specific patient, it is designed to understand how oncologists would approach this problem. There’s a 50 year old stage...
The forums now look like from the beginnings of the internet (now paragraphs, illogical structure, need to scroll all the time etc..) Are these things...
“Gratitude is one of the most medicinal emotions we can feel.” (Sara Avant Stover) Thank you for joining GRACE in our #LCAM15 activities.
Dr. Jack West reviews the Lung Cancer Master Protocol for second line treatment of patients with advanced squamous NSCLC, an "umbrella protocol" in which all patients undergo molecular testing and have treatment assigned by the results.
Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.
On this Thanksgiving Day, we salute lung cancer patient Jason Karg and his wife Kristyl for reminding us of the important things in life. November is Lung Cancer Awareness Month. What are you grateful for?
Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.
Dr. Ross Camidge discusses a clinical trial studying patients with advanced stage lung cancer to identify those who may respond to a drug called ponatinib. Both small cell and non small cell lung cancer patients may be eligible. http://bit.ly/UCponatinib
Dr. Seema Nagpal insists on one thing from her lung cancer patients: Proof that they are enjoying their lives. November is Lung Cancer Awareness Month. What are you grateful for?
Dr. Jack West reviews treatment options for patients with an EGFR activating mutation and acquired resistance but no T790M mutation, focusing on a clinical trial with the novel hypoxia-induced pan-HER inhibitor TH4000.
Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a first line treatment for patients with advanced NSCLC and highlights details of two trials testing this question.
Drs. Ben Solomon, Leora Horn, & Jack West assess the utility and limitations of "liquid biopsies", serum-based testing for molecular marker testing in lung cancer.
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock